Global advisory and clinical research company Alira Health has announced a partnership with Sancare, a French artificial intelligence (AI)-driven healthtech company.
As part of this collaboration, the companies will work together to unlock ‘Realli’, a comprehensive source of deep hospital Electronic Medical Record (EMR) data linked with claims data obtained from a federated network of hospitals in France, supported with AI.
Realli offers near real-time access to comprehensive EMR content from partner hospitals, linked with claims data, which helps in reducing the time needed to obtain study results.
Alira Health chief access officer Jean-François Ricci said: “Through the partnership between Alira Health and Sancare, we combine our strengths to create a comprehensive, end-to-end service offering that enables data access, analytics, and evidence generation strategy, providing impactful, real-world solutions with purpose for patients.
“Our collaboration creates a central source for study design, data analysis, and communication of actionable insights that address needs for clinical research and market access in France and beyond.”
The partnership is further expected to accelerate innovation in healthcare by leveraging Alira Health’s industry expertise and Sancare’s advanced technology in hospital data systems.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The two companies will optimise development processes and expand access to healthcare solutions together, benefiting patients and healthcare providers.
In addition, this integration will enable access to large volumes of in-depth clinical data, together with claims data from hospitals, providing significant value throughout the drug and MedTech lifecycle.
Alira Health brings approximately two decades of experience working in the life sciences industry while Sancare contributes its proficiency in developing the Realli solution.
Sancare CEO Thomas Duval said: “Our partnership brings new capabilities for healthcare and life sciences organisations, especially for Real-World Evidence studies and for data owners.
“By uniting Alira Health’s strengths as a Global Advisory and Contract Research Organisation with Sancare’s technology, data, and network, we enable important new evidence resources for companies developing solutions for patients.”